CTRI/2010/091/000619进行中（未招募）3 期
Axitinib (AG-013736) For the Treatment of Metastatic Renal Cell Cancer - Not Applicable
试验速览
- 阶段
- 3 期
- 状态
- 进行中（未招募）
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1. Ages Eligible for Study:18 Years and older,
- •2. Genders Eligible for Study:Both,
- •3. Accepts Healthy Volunteers:No,
- •4. Histologically documented metastatic renal cell cancer with a component of clear cell histology.
- •5. Evidence of measurable disease.
- •6. Patients with mRCC must have received no prior systemic first-line therapy or must have progressive disease per RECIST (version 1.0) after one prior systemic first line regimen for metastatic disease containing sunitinib, cytokine(s), or both.
- •The upper age limit is not defined in the protocol.
排除标准
- •-Prior treatment for metastatic renal cell cancer with more that one systemic first line therapy.
- •-Major surgery less that 4 weeks or radiation less than 2 weeks of starting study drug.
研究者
相似试验
进行中（未招募）
1 期
AG-013736 (axitinib) for the treatment of metastatic renal cell cancer (mRCC) - Specific for Bulgaria onlymetastatic renal cell cancerMedDRA version: 15.0Level: PTClassification code 10050513Term: Metastatic renal cell carcinomaSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)EUCTR2010-018585-23-BGPfizer Inc 235 East 42nd Street, New York, NY10017447
已完成
2 期
A Phase II Study of Axitinib in Patients With Metastatic Renal Cell Cancer Unsuitable for NephrectomyClear-cell Metastatic Renal Cell CarcinomaNCT01693822Institute of Cancer Research, United Kingdom65
已完成
3 期
Axitinib (AG-013736) For the Treatment of Metastatic Renal Cell CancerKidney NeoplasmsNCT00920816Pfizer492
已完成
2 期
A Phase II Study of Axitinib in Metastatic Non-clear Cell Renal Cell Carcinoma Patients Previously Treated With TemsirolimusNonclear CellTemsirolimus ResistanceRenal Cell CarcinomaNCT01798446Seoul National University Hospital41
进行中（未招募）
1 期
Axitinib Treatment for Widespread Kidney Cancer Unsuitable for SurgeryMetastatic renal cell carcinomaMedDRA version: 19.0Level: LLTClassification code 10050076Term: Metastatic renal carcinomaSystem Organ Class: 100000004864EUCTR2011-004562-16-GBInstitute of Cancer Research